These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


931 related items for PubMed ID: 10430122

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
    Mahoney MC, Robinson-Smith TM, Shaughnessy EA.
    AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
    [Abstract] [Full Text] [Related]

  • 3. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q, Montemezzi S, D'Atri C.
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
    Renshaw AA, Gould EW.
    Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
    [Abstract] [Full Text] [Related]

  • 7. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
    Berg WA, Mrose HE, Ioffe OB.
    Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance.
    Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH.
    Radiology; 2000 Sep; 216(3):831-7. PubMed ID: 10966718
    [Abstract] [Full Text] [Related]

  • 10. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision.
    Murray MP, Luedtke C, Liberman L, Nehhozina T, Akram M, Brogi E.
    Cancer; 2013 Mar 01; 119(5):1073-9. PubMed ID: 23132235
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy.
    Shin SJ, Rosen PP.
    Arch Pathol Lab Med; 2002 Jun 01; 126(6):697-701. PubMed ID: 12033958
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
    Rendi MH, Dintzis SM, Lehman CD, Calhoun KE, Allison KH.
    Ann Surg Oncol; 2012 Mar 01; 19(3):914-21. PubMed ID: 21861212
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
    Lewis JL, Lee DY, Tartter PI.
    Ann Surg Oncol; 2012 Dec 01; 19(13):4124-8. PubMed ID: 22847126
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 47.